Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in GMAB — Genmab A/S

CIK 820027 MINNEAPOLIS, MN
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,653,885
-$7,535 QoQ
Shares Held
60,207
-2.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 292 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. GMAB ranks #135 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,604,822 $1,293,893,227
2 INSM
INSMED Inc
 6,179,571 $658,865,856
3 JAZZ
Jazz Pharmaceuticals plc
 1,215,523 $292,904,576
4 RVMD
Revolution Medicines, Inc.
 1,039,702 $194,715,388
5 ARGX
Argenx SE
 181,464 $168,356,853
6 REGN
Regeneron Pharmaceuticals, Inc.
 227,457 $141,828,535
7 MDGL
Madrigal Pharmaceuticals, Inc.
 231,205 $124,145,521
8 BBIO
BridgeBio Pharma, Inc.
 1,551,663 $115,567,858

All Filings in GMAB

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,653,885 60,207
2026-03-31 $1,661,420 61,924
2025-12-31 $1,893,891 61,490
2025-09-30 $1,814,927 59,176
2025-06-30 $1,171,711 56,714
2024-03-31 $209,249 6,996
2023-09-30 $221,071 6,268
2023-06-30 $225,436 5,931
2023-03-31 $201,259 5,330
2022-12-31 $235,547 5,558
2022-03-31 $205,103 5,669
2021-12-31 $493,746 12,481
2021-09-30 $255,993 5,858
2021-06-30 $229,708 5,626
2021-03-31 $231,221 7,043
2020-12-31 $1,478,681 36,367
2020-09-30 $1,228,521 33,557
2020-06-30 $203,272 5,998
2020-03-31 $891,441 42,069